{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Standing Questioned Before the Federal Circuit in <i>Momenta Pharms. v. Bristol-Myers Squibb Co.</i>",
    "url": "https://www.lexblog.com/2018/01/05/standing-questioned-federal-circuit-momenta-pharms-v-bristol-myers-squibb-co/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-RH1EGRR3",
        "url": "https://www.lexblog.com/lib/RH1EGRR3/"
    },
    "datePublished": "2018-01-05T16:28:28-05:00",
    "dateModified": "2021-11-09T11:02:08-05:00",
    "author": {
        "@type": "Person",
        "name": "Nicole M. DeAbrantes"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Intellectual Property",
    "sourceUrl": "http://www.biosimilarsip.com/?p=4225",
    "sourceStability": "may-move"
}